Alicia Secor

Alicia Secor is the founder of Atalanta Therapeutics. Atalanta Therapeutics has raised $262M, latest Series B $97M (2025). Biotech · Boston, MA.

About Alicia Secor

Alicia Secor is the founder of Atalanta Therapeutics. Atalanta Therapeutics operates in Biotech and is based in Boston, MA. Atalanta Therapeutics has raised $262M, latest Series B $97M (2025). Backers on record include Stephen Knight, F-Prime, F-Prime Capital.

Alicia Secor at a glance

Company
Atalanta Therapeutics
Industry
Biotech
Location
Boston, MA
Total raised
$262M
Investors on record
Stephen Knight, F-Prime, F-Prime Capital

Frequently asked about Alicia Secor

Who is Alicia Secor?
Alicia Secor is the founder of Atalanta Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Alicia Secor found?
Alicia Secor founded Atalanta Therapeutics, a Biotech company based in Boston, MA.
How do I contact Alicia Secor?
Verified contact routes including LinkedIn, background and funding history for Alicia Secor are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Boston — who backed them, at what stage, and how much they raised.

Atalanta Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades